sr 33557 has been researched along with phosphocreatine in 1 studies
Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
---|---|---|---|---|---|
50 | 3 | 1 | 7,475 | 329 | 575 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatelain, P; Laruel, R; Manning, AS; Muller, RN; Van Haverbeke, Y; Vander Elst, L | 1 |
1 other study(ies) available for sr 33557 and phosphocreatine
Article | Year |
---|---|
31P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heart.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Coronary Circulation; Cytosol; Heart; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Indolizines; Intracellular Fluid; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Perfusion; Phenethylamines; Phosphocreatine; Phosphorus; Rats; Rats, Wistar; Ventricular Function, Left | 1994 |